Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenlian Hewei
- Development stage
- Unknown
- Lead developer
- Nanjing Shenqu Pharmaceutical Technology Service
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shenlian Hewei is a Traditional Chinese Medicine (TCM) candidate developed by Nanjing Shenqu Pharmaceutical Technology Service Co., Ltd. for the treatment of chronic non-atrophic gastritis (superficial gastritis). Formulated as granules, it is designed to harmonize the stomach and alleviate symptoms such as epigastric pain, bloating, and acid reflux, specifically targeting the spleen and stomach qi deficiency with damp-heat syndrome. The drug has undergone clinical evaluation in China, reaching Phase 3 trials to assess its efficacy in improving clinical symptoms and gastric mucosal lesions. As a multi-component herbal formulation, its therapeutic effects are attributed to the synergistic action of its constituent herbs, which traditionally include ingredients like Ginseng and Lotus, aimed at clearing heat, resolving dampness, and protecting the gastric lining.
- Brand names
- Shenlian Hewei
- Other names
- Shenlian Hewei Granules参莲和胃颗粒
Beyond the preview
Go deeper on Shenlian Hewei.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenlian Hewei.